Intimation of Monitoring Agency Report for the quarter ended 30.09.2025
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Limited has submitted the Monitoring Agency Report for the quarter ended 30 September 2025 (Q2 FY26) to the stock exchanges. A Monitoring Agency is appointed by companies that raise money from the public (such as through an IPO) to track how the funds raised are actually being used versus the stated purpose. This filing confirms the company is complying with its post-listing obligations to report on the deployment of IPO proceeds on a quarterly basis. Investors would need to view the full report to check the actual utilisation figures, any deviations from the original plan, and the monitoring agency's comments.
This is a routine compliance filing and is not an earnings or business update. Shareholders should look at the attached Monitoring Agency Report to verify that IPO funds are being used as promised — any major deviation could be a red flag, while on-track utilisation is a neutral-to-positive signal.